International Stem Cell Corporation Appoints MZ Group as its Investor Relations Firm

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO) (www.internationalstemcell.com) today announced it has appointed MZ Group as its investor relations advisor. MZ will assist International Stem Cell with investor relations consulting, corporate communications and investor and shareholder outreach. ISCO also announced the promotion of Dr. Simon Craw to the position of Executive Vice President with responsibility for Business Development and Investor Relations.

MORE ON THIS TOPIC